205 related articles for article (PubMed ID: 15764732)
1. Primate trace amine receptor 1 modulation by the dopamine transporter.
Miller GM; Verrico CD; Jassen A; Konar M; Yang H; Panas H; Bahn M; Johnson R; Madras BK
J Pharmacol Exp Ther; 2005 Jun; 313(3):983-94. PubMed ID: 15764732
[TBL] [Abstract][Full Text] [Related]
2. Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.
Xie Z; Westmoreland SV; Bahn ME; Chen GL; Yang H; Vallender EJ; Yao WD; Madras BK; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):116-27. PubMed ID: 17234900
[TBL] [Abstract][Full Text] [Related]
3. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
4. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake.
Zsilla G; Hegyi DE; Baranyi M; Vizi ES
Eur J Pharmacol; 2018 Oct; 837():72-80. PubMed ID: 30172789
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
Bunzow JR; Sonders MS; Arttamangkul S; Harrison LM; Zhang G; Quigley DI; Darland T; Suchland KL; Pasumamula S; Kennedy JL; Olson SB; Magenis RE; Amara SG; Grandy DK
Mol Pharmacol; 2001 Dec; 60(6):1181-8. PubMed ID: 11723224
[TBL] [Abstract][Full Text] [Related]
7. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
8. Trace amine-associated receptor 1 is a modulator of the dopamine transporter.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2007 Apr; 321(1):128-36. PubMed ID: 17234899
[TBL] [Abstract][Full Text] [Related]
9. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
10. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain.
De La Garza R; Meltzer PC; Madras BK
Synapse; 1999 Oct; 34(1):20-7. PubMed ID: 10459168
[TBL] [Abstract][Full Text] [Related]
11. Cloning of the cocaine-sensitive bovine dopamine transporter.
Usdin TB; Mezey E; Chen C; Brownstein MJ; Hoffman BJ
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11168-71. PubMed ID: 1722321
[TBL] [Abstract][Full Text] [Related]
12. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum.
Kanthasamy A; Sprague JE; Shotwell JR; Nichols DE
Neuroscience; 2002; 114(4):917-24. PubMed ID: 12379247
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
14. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
15. 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.
Metzger RR; Hanson GR; Gibb JW; Fleckenstein AE
Eur J Pharmacol; 1998 May; 349(2-3):205-10. PubMed ID: 9671099
[TBL] [Abstract][Full Text] [Related]
16. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
17. 3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.
Rizzo FR; Federici M; Mercuri NB
Neuroscience; 2018 May; 377():69-76. PubMed ID: 29510210
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.
Xie Z; Vallender EJ; Yu N; Kirstein SL; Yang H; Bahn ME; Westmoreland SV; Miller GM
J Neurosci Res; 2008 Nov; 86(15):3435-46. PubMed ID: 18627029
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
20. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
